Literature DB >> 23342182

Criticial limb ischemia: epidemiology.

Mark G Davies1.   

Abstract

Critical limb ischemia is found in 12% of the U.S. adult population. Its clinical presentation varies from no symptoms to intermittent claudication, atypical leg pain, rest pain, ischemic ulcers, or gangrene. Those with critical limb ischemia have a high incidence of cardiovascular comorbidities that reflect a significant systemic atherosclerotic burden; they have increased functional impairment and increased rates of functional decline compared with persons without critical limb ischemia. Interventions for critical limb ischemia and the impact of major amputation have a significant social and economic impact. At 1 year, 25% of patients will be dead, 30% will have undergone amputation, and only 45% will remain alive with both limbs. At 5 years, more than 60% of patients with critical limb ischemia will be dead.

Entities:  

Keywords:  amputation; cardiovascular disease; cardiovascular risk factors; claudication; critical limb ischemia; peripheral arterial disease

Mesh:

Year:  2012        PMID: 23342182      PMCID: PMC3549644          DOI: 10.14797/mdcj-8-4-10

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  61 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

3.  D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease.

Authors:  A Komarov; E Panchenko; A Dobrovolsky; Yu Karpov; A Deev; E Titaeva; K Davletov; A Eshkeeva; L Markova
Journal:  Eur Heart J       Date:  2002-08       Impact factor: 29.983

4.  Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.

Authors:  J Selhub; P F Jacques; A G Bostom; P W Wilson; I H Rosenberg
Journal:  Public Health Rev       Date:  2000

5.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

6.  Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study.

Authors:  Thomas J Wang; Byung-Ho Nam; Peter W F Wilson; Philip A Wolf; Daniel Levy; Joseph F Polak; Ralph B D'Agostino; Christopher J O'Donnell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

7.  Peripheral arterial disease and depressed mood in older men and women.

Authors:  A Arseven; J M Guralnik; E O'Brien; K Liu; M M McDermott
Journal:  Vasc Med       Date:  2001-11       Impact factor: 3.239

8.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

9.  UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.

Authors:  Amanda I Adler; Richard J Stevens; Andrew Neil; Irene M Stratton; Andrew J M Boulton; Rury R Holman
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

10.  Coagulation in diabetic and non-diabetic claudicants.

Authors:  I Gosk-Bierska; R Adamiec; P Alexewicz; W E Wysokinski
Journal:  Int Angiol       Date:  2002-06       Impact factor: 2.789

View more
  21 in total

1.  Decision-Making in Critical Limb Ischemia: A Markov Simulation.

Authors:  Aaron J Deutsch; C Charles Jain; Kimberly G Blumenthal; Mark W Dickinson; Anne M Neilan
Journal:  Ann Vasc Surg       Date:  2017-07-21       Impact factor: 1.466

Review 2.  Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.

Authors:  Giovanni Di Minno; Gaia Spadarella; Giovanni Cafaro; Maurizio Petitto; Roberta Lupoli; Alessandro Di Minno; Giovanni de Gaetano; Elena Tremoli
Journal:  Ann Med       Date:  2014-07-21       Impact factor: 4.709

Review 3.  Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option.

Authors:  Joshua P H Neale; James T Pearson; Rajesh Katare; Daryl O Schwenke
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-13       Impact factor: 5.555

Review 4.  Peripheral Mechanisms of Ischemic Myalgia.

Authors:  Luis F Queme; Jessica L Ross; Michael P Jankowski
Journal:  Front Cell Neurosci       Date:  2017-12-22       Impact factor: 5.505

5.  A comparative study on endovascular treatment of (sub)acute critical limb ischemia: mechanical thrombectomy vs thrombolysis.

Authors:  Mariya Kronlage; Ilka Printz; Britta Vogel; Erwin Blessing; Oliver J Müller; Hugo A Katus; Christian Erbel
Journal:  Drug Des Devel Ther       Date:  2017-04-18       Impact factor: 4.162

6.  Evaluating the potential of endothelial cells derived from human induced pluripotent stem cells to form microvascular networks in 3D cultures.

Authors:  Jonathan R Bezenah; Yen P Kong; Andrew J Putnam
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

7.  Dual Modulation of Nociception and Cardiovascular Reflexes during Peripheral Ischemia through P2Y1 Receptor-Dependent Sensitization of Muscle Afferents.

Authors:  Luis F Queme; Jessica L Ross; Peilin Lu; Renita C Hudgins; Michael P Jankowski
Journal:  J Neurosci       Date:  2016-01-06       Impact factor: 6.167

8.  National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013.

Authors:  Youn Young Park; Jin Hyun Joh; Sang-Ah Han; Sang Hyun Kim; Sungsin Cho; Ho-Chul Park; Hyung Joon Ahn
Journal:  Ann Surg Treat Res       Date:  2015-11-27       Impact factor: 1.859

9.  Delivery of Human Stromal Vascular Fraction Cells on Nanofibrillar Scaffolds for Treatment of Peripheral Arterial Disease.

Authors:  Caroline Hu; Tatiana S Zaitseva; Cynthia Alcazar; Peter Tabada; Steve Sawamura; Guang Yang; Mimi R Borrelli; Derrick C Wan; Dung H Nguyen; Michael V Paukshto; Ngan F Huang
Journal:  Front Bioeng Biotechnol       Date:  2020-07-17

10.  MiR-323b-5p acts as a novel diagnostic biomarker for critical limb ischemia in type 2 diabetic patients.

Authors:  Biao Cheng; Ju-Yi Li; Xiao-Chao Li; Xiu-Fang Wang; Zhong-Jing Wang; Jue Liu; Ai-Ping Deng
Journal:  Sci Rep       Date:  2018-10-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.